Market closed
Creative Medical Technology Holdings Inc./$CELZ
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Ticker
$CELZ
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
4
ISIN
US22529Y4089
CELZ Metrics
BasicAdvanced
$251M
-
-$3.71
4.60
-
Price and volume
Market cap
$251M
Beta
4.6
52-week high
$6.77
52-week low
$1.69
Average daily volume
73K
Financial strength
Current ratio
18.726
Quick ratio
18.131
Total debt to equity
0.224
Management effectiveness
Return on assets (TTM)
-41.30%
Return on equity (TTM)
-65.85%
Valuation
Price to revenue (TTM)
288.022
Price to book
0.59
Price to tangible book (TTM)
0.64
Price to free cash flow (TTM)
-0.576
Growth
Revenue change (TTM)
22.22%
Earnings per share change (TTM)
-1.20%
3-year revenue growth (CAGR)
-49.95%
3-year earnings per share growth (CAGR)
-59.56%
CELZ News
AllArticlesVideos
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
GlobeNewsWire·2 months ago
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Creative Medical Technology Holdings Inc. stock?
Creative Medical Technology Holdings Inc. (CELZ) has a market cap of $251M as of May 11, 2025.
What is the P/E ratio for Creative Medical Technology Holdings Inc. stock?
The price to earnings (P/E) ratio for Creative Medical Technology Holdings Inc. (CELZ) stock is 0 as of May 11, 2025.
Does Creative Medical Technology Holdings Inc. stock pay dividends?
No, Creative Medical Technology Holdings Inc. (CELZ) stock does not pay dividends to its shareholders as of May 11, 2025.
When is the next Creative Medical Technology Holdings Inc. dividend payment date?
Creative Medical Technology Holdings Inc. (CELZ) stock does not pay dividends to its shareholders.
What is the beta indicator for Creative Medical Technology Holdings Inc.?
Creative Medical Technology Holdings Inc. (CELZ) has a beta rating of 4.6. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.